Migraine Headaches Clinical Trials 2023

What are the top hospitals conducting migraine headaches research?

For those living with the debilitating effects of migraine headaches, finding relief can often be a challenging journey. However, several hospitals across the United States are diligently working to change that narrative through their commitment to cutting-edge clinical trials. In Bellevue, Washington, Northwest Clinical Research Center takes the lead with an impressive 12 ongoing migraine headaches trials and a cumulative total of 37 studies dedicated to understanding this condition. Since recording its first trial in 2014, this research center has been at the forefront of advancements in migraine treatment.

Meanwhile, Clinvest Research LLC in Springfield is making significant strides as well. With nine active migraine headaches trials and a history encompassing 17 previous studies since their initial trial in 2018, they are actively seeking new solutions for those plagued by migraines.

In another part of Ohio lies Cincinnati Children's Hospital Medical Center which is playing a crucial role in unraveling the mysteries surrounding migraines. This renowned hospital currently hosts eight active clinical trials centered around migraines while having conducted an additional thirteen studies since embarking on their first trial back in 2012.

Boston also houses one such institution devoted to pioneering migraine research: Boston Clinical Trials. With eight ongoing clinical tests aimed at alleviating these severe headaches and twenty-three previously completed investigations dating back to their inaugural study in 2015; they too remain steadfastly committed towards advancing our understanding of this condition.

Finally joining forces in Stamford Connecticut would be New England Institute for Clinical Research where seven present-day experiments continue evaluating potential treatments while simultaneously striving forward using insights accumulated throughout sixteen past explorations from starting out into possible remedies just about ten years ago during2012

These hospitals' dedication underscores not only the severity and complexity of migraines but also serves as a beacon of hope for sufferers worldwide who yearn for effective relief options. The collective efforts made by these leading institutions remind us that every breakthrough achieved through rigorous research brings us closer to providing much-needed respite to those burdened by the throbbing pain of migraines.

Which are the best cities for migraine headaches clinical trials?

When it comes to clinical trials for migraine headaches, several cities stand out as hubs of research and development. Miami, Florida leads the pack with 45 active trials focusing on medications like Lasmiditan, Ubrogepant, and Rimegepant/BHV3000. Cincinnati, Ohio follows closely behind with 37 ongoing studies investigating treatments such as Rimegepant/BHV3000, Ubrogepant, and Fremanezumab. Additionally, Dallas in Texas offers 26 active trials exploring potential solutions like Ubrogepant, Fremanezumab, and Atogepant 60 mg. These cities provide individuals suffering from migraines access to cutting-edge clinical trials that pave the way for advanced treatments and improved quality of life.

Which are the top treatments for migraine headaches being explored in clinical trials?

Migraine headaches, a common and debilitating condition, are the focus of ongoing clinical trials exploring innovative treatments. Leading the pack is fremanezumab, currently involved in three active trials and contributing to 13 all-time studies dedicated to migraine headaches since its introduction in 2016. Not far behind is eptinezumab, making waves with three active trials and participating in 12 all-time studies since its debut in 2019. In addition to pharmaceutical approaches, emotional awareness and expression therapy (EAET) has also emerged as a contender with two active trials focusing on this novel treatment method that was first listed for study in 2023. Also showing promise are erenumab dose 3 and galcanezumab, both engaged in two active trials each while accumulating valuable data from previous research endeavors. With these exciting developments underway, hope remains high for finding effective solutions to alleviate the burden of migraine headaches on those affected by this condition.

What are the most recent clinical trials for migraine headaches?

Recent clinical trials have brought new hope for individuals suffering from migraine headaches. Among these trials are studies on atogepant, a potential treatment that has entered Phase 3 and shows promise in managing migraines. Another notable trial is the ReMMiD-C Therapeutic Arm A study, also in Phase 3, which investigates a therapeutic approach specifically designed for migraine headaches. Additionally, research on greater occipital nerve block groups aims to explore innovative methods to alleviate the symptoms of migraines. These breakthroughs provide optimism for improved management and relief for those affected by this debilitating condition.

What migraine headaches clinical trials were recently completed?

Several recent clinical trials have made significant progress in the field of migraine headache treatment. In March 2022, a trial sponsored by Allergan concluded its investigation into Ubrogepant's efficacy for managing migraines. Similarly, Eli Lilly and Company completed a trial on Galcanezumab in December 2021, while H. Lundbeck A/S finalized their study on Lu AG09222 in November of the same year. Additionally, Satsuma Pharmaceuticals' investigation of Dihydroergotamine wrapped up in June 2021. These important advancements underscore ongoing efforts to develop effective therapies for individuals suffering from debilitating migraine headaches.